Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Mast Cell Neoplasms, CD2/CD25

Peter Valent

MD

🏢Medical University of Vienna🌐Austria

Professor of Internal Medicine and Hematology

78
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Peter Valent has been a pioneer in defining the diagnostic criteria and biology of mast cell neoplasms, establishing CD2 and CD25 as aberrant mast cell markers and contributing to the WHO classification of systemic mastocytosis that guides clinical management. His research has characterized mast cell progenitors and their malignant counterparts in systemic mastocytosis and mast cell leukemia. He has identified prognostic markers and novel therapeutic targets for aggressive mast cell neoplasms. His work has been foundational for the modern understanding and treatment of mast cell diseases.

Share:

🧪Research Fields 研究领域

mast cell neoplasm diagnosis
mastocytosis WHO classification
CD2 CD25 mast cell
mast cell leukemia biology
mast cell progenitor cancer

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Peter Valent 的研究动态

Follow Peter Valent's research updates

留下邮箱,当我们发布与 Peter Valent(Medical University of Vienna)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment